Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teleflex Inc (NY: TFX )

198.62 -2.11 (-1.05%)
Official Closing Price Updated: 6:30 PM EDT, Jun 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teleflex Inc

< Previous 1 2 3 4 5 6 7 Next >
Peering Into Teleflex's Recent Short Interest
Via Benzinga
Teleflex Publishes 2023 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug Administration 
From Teleflex Incorporated
Via GlobeNewswire
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
From Teleflex Incorporated
Via GlobeNewswire
Expert Ratings For Teleflex
Via Benzinga
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
How Is The Market Feeling About Teleflex?
Via Benzinga
TFX Stock Earnings: Teleflex Beats EPS, Beats Revenue for Q1 2024
TFX stock results show that Teleflex beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
Teleflex: Dividend Insights
Via Benzinga
Breaking Down Teleflex: 4 Analysts Share Their Views
Via Benzinga
Preview: Teleflex's Earnings
Via Benzinga
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the BofA Securities 2024 Health Care Conference
From Teleflex Incorporated
Via GlobeNewswire
Forecasting The Future: 10 Analyst Projections For Teleflex
Via Benzinga
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
From Teleflex Incorporated
Via GlobeNewswire
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
Teleflex commits to reach net-zero greenhouse gas emissions across its value chain by 2050. 
From Teleflex Incorporated
Via GlobeNewswire
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
From Glancy Prongay & Murray LLP
Via Business Wire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
From Teleflex Incorporated
Via GlobeNewswire
Earnings Scheduled For February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
Via Benzinga
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
3 Top Stock Picks from America’s Leading SMID-Cap Fund
One of the best actively managed mutual funds to buy for SMID-Cap top stock picks is from Eaton Vance. Here are three of the top stocks. 
Via InvestorPlace
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.